


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
PHAR
Pharming Group N.V.
$17.50
PHAR Price Performance
$13.16 (+32.98%)
$14.87 (+17.69%)
$14.25 (+22.81%)
$14.25 (+22.81%)
PHAR has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

High volatilty

PHAR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings increase YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
PHAR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
PHAR Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is PHAR current stock price?
What are PHAR stock strengths?
What is PHAR Risk Level?
What is PHAR market cap and volume?
What is PHAR current Stock IQ?
Should I buy PHAR stock right now?
Is PHAR a Strong Buy right now?
What does a 'Strong Buy' rating mean for PHAR?
What does a 'Strong Sell' rating mean for PHAR?
What factors influence PHAR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
PHAR
Pharming Group N.V.
Current Price
$17.50

PHAR Price Performance
$13.16 (+32.98%)
$14.87 (+17.69%)
$14.25 (+22.81%)
$14.25 (+22.81%)
PHAR Analysts Opinion
PHAR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Earnings increase YoY
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
PHAR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
PHAR Street Sentiment is extremely bullish and have positive views on the near-term outlook
PHAR has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

High volatilty

Average key support and resistance price levels
PHAR Stock IQ
PHAR Latest Analysis
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Heres is How to Trade. The mean of analysts price targets for Pharming Group (PHAR) points to an 81.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wed Nov 26, 2025
Pharming Group N.V. (PHAR) Presents at Jefferies London Healthcare Conference 2025 - Slideshow.
Wed Nov 19, 2025
Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect?. The mean of analysts price targets for Pharming Group (PHAR) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Mon Nov 10, 2025
Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy?. Pharming Group N.V. Sponsored ADR (PHAR) shares have started gaining and might continue moving higher in the near term as indicated by solid earnings estimate revisions.
Mon Nov 10, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PHAR Stock trends
PHAR Stock performance
PHAR Stock analysis
PHAR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.